T. Rowe Price Associates’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $493K | Buy |
|
|||||
|
2025
Q3 | $270K | Buy |
|
|||||
|
2025
Q2 | $217K | Sell |
|
|||||
|
2025
Q1 | $484K | Buy |
|
|||||
|
2024
Q4 | $524K | Buy |
|
|||||
|
2024
Q3 | $509K | Buy |
|
|||||
|
2024
Q2 | $515K | Buy |
|
|||||
|
2024
Q1 | $541K | Sell |
|
|||||
|
2023
Q4 | $872K | Sell |
|
|||||
|
2023
Q3 | $2.21M | Sell |
|
|||||
|
2023
Q2 | $19.7M | Buy |
|
|||||
|
2023
Q1 | $9.01M | Buy |
|
|||||
|
2022
Q4 | $9.76M | Buy |
|
|||||
|
2022
Q3 | $7.44M | Buy |
|
|||||
|
2022
Q2 | $4.5M | Sell |
|
|||||
|
2022
Q1 | $11.6M | Sell |
|
|||||
|
2021
Q4 | $25M | Buy |
|
|||||
|
2021
Q3 | $1.59M | Sell |
|
|||||
|
2021
Q2 | $3.59M | Buy |
|
|||||
|
2021
Q1 | $3.18M | Sell |
|
|||||
|
2020
Q4 | $1.75M | Buy |
|
|||||
|
2020
Q3 | $908K | Buy |
|